Skip to content

A comparative study of outcomes of pregnancy and delivery in overweight/obese patients with PCOS treated with exenatide or metformin

A comparative study of outcomes of pregnancy and delivery in overweight/obese patients with PCOS treated with exenatide or metformin

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900020516
Enrollment
Unknown
Registered
2019-01-05
Start date
2016-02-01
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

polycystic ovarian syndrome

Interventions

2:lifestyle counselling and metformin

Sponsors

The third affiliated hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Aged 22 to 40 years old; 2. The diagnostic criteria for PCOS are based on the revised 2003 Rotterdam European Society of Human Reproduction and Embryology (ESHRE)/American Society of Reproductive Medicine (ASRM) PCOS Consensus Workshop Group diagnostic criteria and have two of the following three: (1) oligo- and/or anovulation; (2) clinical and/or biochemical signs of hyperandrogenism; (3) ovarian enlargement, at least 12 small follicles with a diameter of 2 ~ 9mml on each side and / or unilateral or bilateral ovarian volume =10ml. With exclusion of congenital adrenal hyperplasia or other known causes of ovarian tumors that secrete testosterone. 3. Body mass index = 24kg / m2; 4. Plan to conceive, but agree to use non-pharmacological contraception in three months; 5. Agree to follow up in our hospital during pregnancy and give birth in our hospital.

Exclusion criteria

Exclusion criteria: 1. used drugs that affect glycolipid metabolism and sex hormone levels recently; 2. Other endocrine diseases such as hyperprolactinemia, congenital adrenal hyperplasia (CAH); hyperprolactinemia and other endocrine diseases that produce high androgen, such as Cushing's syndrome, and tumors that secrete androgen; 3. Autoimmune disease, cancer, type 1, or type 2 diabetes; 4. Drug treatment: have taken cortisol, antidepressants, hypoglycemic drugs, hormonal contraceptives, ovulation promoting drugs or other drugs which judged by researchers in the past 12 weeks; 5. Plan for pregnancy in 3 months or no pregnancy requirements; 6. Need to deliver in the other hospitals for various reasons; 7. Have language barrier or unable to understand the requirements of the experiment; 8. Severe liver and kidney function, other organ failure or mental illness.

Design outcomes

Primary

MeasureTime frame
Pregnancy outcome;weight;HOMA-IR;

Secondary

MeasureTime frame
anthropometric measurements;glucolipids metabolism index;Insulin level;sex hormone levels;The inflammatory factor level;blood pressure;

Countries

China

Contacts

Public ContactZhang Ying

The third affiliated hospital of Guangzhou Medical University

zhangying30412@163.com+86 18928916685

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026